SCHEMBL21486288

SCHEMBL21486288

CNCc1nc2cc(C)ccc2[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.61
KMT2A Q03164 5/20 0.50
POLB P06746 2/20 0.50
SMN1; SMN2 Q16637 6/20 0.46
RAB9A P51151 6/20 0.46
NPC1 O15118 5/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
GAA P10253 2/20 0.45
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 3/20 0.43
MAPT P10636 2/20 0.43
GFER P55789 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16188975 0.87 KMT2A (0.68) PKMKMT2APOLBSMN1; SMN2RAB9A
SCHEMBL12467653 0.84 KMT2A (0.55) PKMKMT2APOLBSMN1; SMN2RAB9A
SCHEMBL16188992 0.82 PKM (0.59) PKMKMT2APOLBSMN1; SMN2RAB9A
SCHEMBL24376403 0.82 PKM (0.59) PKMKMT2APOLBSMN1; SMN2RAB9A
SCHEMBL7366882 0.82 PKM (0.59) PKMRAB9ACYP1A2CYP2C9CYP2C19
SCHEMBL11296982 0.81 SMN1; SMN2 (0.61) PKMKMT2APOLBSMN1; SMN2RAB9A
SCHEMBL11633661 0.81 KMT2A (0.59) PKMKMT2APOLBSMN1; SMN2RAB9A
SCHEMBL10038839 0.81 DDAH1 (0.59) KMT2APOLBSMN1; SMN2RAB9ANPC1
SCHEMBL27283611 0.80 SMN1; SMN2 (0.56) PKMKMT2APOLBSMN1; SMN2RAB9A
SCHEMBL16188974 0.79 KMT2A (0.64) PKMKMT2APOLBGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260138071-A1 SULFIDE GAS REMOVAL PROCESS KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-05-21 US disclosed
US-20260014514-A1 METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-15 US disclosed
US-20260014197-A1 DRUG DELIVERY SYSTEM IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2026-01-15 US disclosed
US-20260014517-A1 HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-15 US disclosed
US-20260008009-A1 PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-08 US disclosed
US-20260002088-A1 PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-01 US disclosed
US-20250381514-A1 METHOD FOR REMOVING HYDROGEN SULFIDE FROM SOUR GAS KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-12-18 US disclosed
US-12459862-B2 Cement paste composition KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-11-04 US disclosed
US-12427499-B2 Process for removing hydrogen sulfide from sour gases KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-09-30 US disclosed
US-12415726-B2 Process for simultaneous removal of hydrogen sulfide and heavy metals KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-09-16 US disclosed
US-20240082809-A1 PROCESS FOR REMOVING HYDROGEN SULFIDE FROM SOUR GASES KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-03-14 US disclosed
US-20240018406-A1 MANGANESE OXIDE SULFIDE CAPTURE DRILLING FLUID KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-01-18 US disclosed
US-20230404931-A1 METHOD FOR FORMING A NANOMEDICINAL COMPOSITION IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2023-12-21 US disclosed
US-20230404930-A1 METAL ORGANIC FRAMEWORK/POROUS SILICATE AND/OR ALUMINOSILICATE NANOCARRIER FOR BLASTOCYSTOSIS TREATMENT IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2023-12-21 US disclosed
US-20230404932-A1 METHOD FOR TREATING BLASTOCYSTIS INFECTION IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2023-12-21 US disclosed
US-11826477-B1 Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2023-11-28 US disclosed
US-11746278-B1 Method of removing sulfide-containing scale KING FAHD UNIVERSITY OF PETROLEUM AND (SA) 2023-09-05 US disclosed
US-11708517-B1 Hydrogen sulfide mitigating drilling fluid and method of drilling subterranean geological formation KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2023-07-25 US disclosed
US-20200269194-A1 POROUS MEMBRANE CONTAINING METAL-ORGANIC FRAMEWORKS KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2020-08-27 US disclosed
EP-2780026-B1 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME (US) 2019-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008009-A1 PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION HMOX2, HMOX1, SCO2 PKM 3338/4885KMT2A 2337/4885POLB 951/4885
US-20260014517-A1 HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION TST, SOD1, SAMM50 PKM 202/4885KMT2A 626/4885POLB 1698/4885
US-11826477-B1 Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment CAT, GPX1, SLC39A11 PKM 948/4885KMT2A 944/4885POLB 2169/4885
US-20230404930-A1 METAL ORGANIC FRAMEWORK/POROUS SILICATE AND/OR ALUMINOSILICATE NANOCARRIER FOR BLASTOCYSTOSIS TREATMENT CAT, GPX1, SLC39A11 PKM 948/4885KMT2A 944/4885POLB 2169/4885
US-20230404932-A1 METHOD FOR TREATING BLASTOCYSTIS INFECTION CAT, GPX1, GPX4 PKM 1031/4885KMT2A 585/4885POLB 2121/4885
US-20260002088-A1 PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION SAMM50, SOD1, HNRNPH3 PKM 222/4885KMT2A 1374/4885POLB 1153/4885
US-20260138071-A1 SULFIDE GAS REMOVAL PROCESS SAMM50, SRSF1, GTF2F1 PKM 579/4885KMT2A 2042/4885POLB 2388/4885
US-20260014514-A1 METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR SOD1, MAFG, HMOX2 PKM 1644/4885KMT2A 2300/4885POLB 1879/4885
US-20230404931-A1 METHOD FOR FORMING A NANOMEDICINAL COMPOSITION GPX1, GPX4, CAT PKM 1100/4885KMT2A 2005/4885POLB 1833/4885
US-20260014197-A1 DRUG DELIVERY SYSTEM IPO8, SLC39A11, SLC2A8 PKM 102/4885KMT2A 559/4885POLB 2344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.